Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

Bioavailability & Absorption

BioPerine, Liposomal Delivery, and Fat Co-Ingestion

Evidence grade 2 of 5, Thin. Read how the Atlas grades evidence.

The written rationale for this grade is still being prepared.

FDA
Not FDA evaluated

Reference only. Not medical advice.

What can go wrong

Piperine can meaningfully alter the pharmacokinetics of medications (including some statins, immunosuppressants, and antiepileptics) by inhibiting their metabolism; anyone on prescription drugs should be cautious. 'Liposomal' is an unregulated marketing term, many products are simply emulsions with no verified liposomal structure. Pay for delivery enhancement only where the molecule actually needs it.

This is something to take to a clinician. The Atlas can tell you what is known about bioavailability & absorption in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.

Delivery-enhancement strategies marketed to improve how much of a supplement reaches the bloodstream: black-pepper extract (piperine/BioPerine), liposomal encapsulation, and taking fat-soluble compounds with a fatty meal. The fat-with-fat-soluble-vitamin principle is sound; piperine has real but ingredient-specific effects; liposomal claims are frequently oversold relative to data.

Absorption tricks matter for some molecules, none for many.

What people take it for

These are the reasons people give for taking it. They are not effects it has been shown to have.

  • Taking vitamin D/K with a fatty meal
  • Adding piperine to improve uptake of certain actives
  • Choosing liposomal formats for poorly-absorbed compounds

How it is supposed to work

Piperine inhibits intestinal and hepatic enzymes (notably CYP3A4) and the P-glycoprotein efflux pump, slowing first-pass metabolism of some co-administered compounds and raising their blood levels. Fat-soluble vitamins (D, K, A, E) require dietary fat for micelle formation and uptake. Liposomes aim to shield an active from gut degradation and improve membrane transit, but real-world bioavailability gains vary enormously by molecule and by how the liposome is actually manufactured.

Enhanced uptake is a double-edged sword

Piperine's mechanism, inhibiting drug-metabolizing enzymes, is the same one that creates drug interactions. The 'absorption booster' that raises your supplement levels can also raise blood levels of prescription drugs metabolized by CYP3A4. The feature is the risk.

What people get wrong

  • Often saidLiposomal always means dramatically better absorption

    ActuallyBioavailability gains are molecule-dependent and often modest; many 'liposomal' products are unverified emulsions.

  • Often saidPiperine boosts everything

    ActuallyPiperine helps specific co-administered actives via enzyme inhibition; it does nothing for many ingredients and can interact with medications.

Who profits, and who pushes back

Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.

At a glance

Piperine (BioPerine)
CYP3A4/P-gp inhibition; effect is ingredient-specific
Fat-soluble vitamins
Better absorbed with dietary fat
Liposomal
Plausible for some actives; claims often exceed evidence

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about Bioavailability & Absorption. A short entry is not a safe entry.

  • Timeline. We have not built the dated record of research and regulatory events.
  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • How it compares. We have not set it against the alternatives.
  • Children and teenagers. We have not checked what is known about younger people.
  • Where we land. We have not taken a position on this yet.

Sources

The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.

The studies that matter

  • Shoba et al., piperine and curcumin bioavailability1998

    20 mg piperine increased curcumin bioavailability roughly 20-fold, the canonical, ingredient-specific result